Abstract:ABSTRACT An Ad26.RSV.preF/RSV preF protein combination vaccine demonstrated 80.0% vaccine efficacy for the prevention of respiratory syncytial virus (RSV)-mediated lower respiratory tract disease in a phase 2b study. In addition to neutralizing antibodies, Fc-effector functions are associated with protective immunity against RSV. Here, vaccine-induced Fc-effector functions were evaluated for the Ad26.RSV.preF/RSV preF protein vaccine in a subset of participants enrolled in a phase 1/2a study. RSV preF-specific antibody subclasses, isotypes, Fcγ receptor binding, and Fc-effector functions were evaluated on days 1 (pre-vaccination), 15, 29, and 183. Compared with Ad26.RSV.preF or RSV preF protein alone, the combination vaccine induced greater Fc-effector functions, including antibody-dependent neutrophil phagocytosis and antibody-dependent natural killer cell activation. Despite RSV pre-exposure, antibody-dependent neutrophil phagocytosis and antibody-dependent natural killer cell activation were not observed at baseline but were induced de novo following vaccination. Compared with the individual vaccine components, the combination vaccine induced a more polyfunctional antibody response. IMPORTANCE Respiratory syncytial virus (RSV) can cause serious illness in older adults (i.e., those aged ≥60 years). Because options for RSV prophylaxis and treatment are limited, the prevention of RSV-mediated illness in older adults remains an important unmet medical need. Data from prior studies suggest that Fc-effector functions are important for protection against RSV infection. In this work, we show that the investigational Ad26.RSV.preF/RSV preF protein vaccine induced Fc-effector functional immune responses in adults aged ≥60 years who were enrolled in a phase 1/2a regimen selection study of Ad26.RSV.preF/RSV preF protein. These results demonstrate the breadth of the immune responses induced by the Ad26.RSV.preF/RSV preF protein vaccine.

[Immune Responses in Rhesus Induced by Recombinant Adenovirus Ad-LMP2].

[Anti-Adenovirus Neutralizing Antibodies and Gag-specific Cellular Immune Responses in Macaca Fascicularis Immunized with Ad5-HIVgag].

The Influence of Recombinant Adenovirus Expression Multiple Epitopes Genes of Foot and Mouth Disease Virus on Specific Immune Responses in Mice

The Construction of Recombinant Adenovirus Inserted with Modified Epstein-Barr Virus Latent Membrane Protein 1 and the Study of Its Immune Effect

Construction of Recombinant Adenovirus Co-expressing VP1-2A of Foot and Mouth Disease Virus and Porcine IL-2 and Its Immune Effects

Immune Responses and Protection Profiles in Mice Induced by Subunit Vaccine Candidates Based on the Extracellular Domain Antigen of Respiratory Syncytial Virus G Protein Combined with Different Adjuvants

Durable Mucosal Simian Immunodeficiency Virus-Specific Effector Memory T Lymphocyte Responses Elicited by Recombinant Adenovirus Vectors in Rhesus Monkeys

Enhancement of Mouse Immune Response by Recombinant Adenovirus Co-Expressing VP1-2A of Foot-and-mouth Disease Virus and Porcine IFN-α

Immune Protection and Mechanism of Plasmid DNA Encoding Gglycoprotein of Respiratory Syncytial Virus(rsv)

Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine

[Immunogenicity of Recombinant Adeno-Asscociated Virus Type 1 Expressing HIV-1 Gp120 Gene in Mice and Rhesus Macaques].

Recombinant influenza virus carrying human adenovirus epitopes elicits protective immunity in mice

Mucosal Immune Response Induced by Recombinant Adenoviruses Expressing Human Rotavirus Genes

Comparison of Immune Responses Induced by the First-generation and the Third-generation Adenoviral Vector by Intrathecal Injection

Induction of Hiv-1-Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 Hiv-1 Vaccination of Humans

[Construction and Immunological Evaluation of Recombinant Adenovirus Containing Codon-Modified HPV 16 L1 Gene].

[Immune Response Induced by HIV DNA Vaccine Combined with Recombinant Adeno-Associated Virus].

The protective effect of intranasal immunization with influenza virus recombinant adenovirus vaccine on mucosal and systemic immune response

Influence of Foot and Mouth Disease Virus of Recombinant Adenovirus Expression VP1 on Specific Immune Responses in Mice

Efficacy of Multivalent Adenovirus-Based Vaccine Against Simian Immunodeficiency Virus Challenge.

Enhanced Immune Responses Against Japanese Encephalitis Virus Using Recombinant Adenoviruses Coexpressing Japanese Encephalitis Virus Envelope and Porcine Interleukin-6 Proteins in Mice.